FIGURE 6.
Median metastasis-free survival (MFS) for the entire cohort was 22.8 months (95% CI 17.5–28.1). A, MFS was similar between FLX and GNP groups. B and C, MFS was superior in patients with marked biochemical response (≥50% decline) and pCR.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.